Quality of life in patients with gastric cancer: translation and psychometric evaluation of the Iranian version of EORTC QLQ-STO22

Sanamber Sadighi, Ali Montazeri, Zahra Sedighi, Mohammad Ali Mohagheghi, Hossein Froutan, Sanamber Sadighi, Ali Montazeri, Zahra Sedighi, Mohammad Ali Mohagheghi, Hossein Froutan

Abstract

Background: Disease and treatment related events, can adversely affect the quality of life of patients with cancer. The purpose of this study was to translate and validate a gastric cancer specific health related quality of life questionnaire (EORTC QLQ-STO22) for Iranian patients suffering from gastric cancer.

Methods: Forward-backward procedure was applied to translate the English language version of the EORTC QLQ-STO22 into Persian (Iranian language). Then, the questionnaire and the EORTC core quality of life instrument (QLQ-C30) were administered to a sample of patients with confirmed diagnosis of gastric cancer. All patients filled in questionnaires before and after one month of treatment. Patients were divided into two groups based on intension of treatment (curative vs. palliative). Reliability and validity of the module was tested by internal consistency and known group comparisons, respectively.

Results: In all, 105 patients were entered into the study. Cronbach's alpha for multi-item scales (to test reliability) ranged from 0.54 to 0.87. The questionnaire discriminated well between clinically distinct subgroups of patients both before and after treatment lending support to its convergent and clinical validity.

Conclusion: Overall, the Iranian version of the EORTC QLQ-STO22 demonstrated a good reliability and clinical validity to support its use in combination with core questionnaire in outcome studies of gastric cancer in Iran. However, using the QLQ-STO22 in a wide range of Iranian patients with gastric cancer should allow further confirmation for its psychometric properties.

References

    1. Smith RP, Shinohara E. Gastric cancer: The Basics. [accessed 26 April 2009]
    1. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, Malvezzi M, La Vecchia C. Recent patterns in gastric cancer: A global overview. Int J Cancer. 2009;125:666–673. doi: 10.1002/ijc.24290.
    1. Kaptein AA, Morita S, Sakomato J. Quality of life in gastric cancer. World J Gastroenterol. 2005;11:3189–3196.
    1. Vickery CW, Blazeby JM, Conroy T, Arraras J, Sezer O, Moore J, Koller, Rosemeyer D, Johnson CD, Alderson D. Development of an EORTC disease-specific quality of life module for use in patients with gastric Cancer. Eur J Cancer. 2001;37:966–971. doi: 10.1016/S0959-8049(00)00417-2.
    1. Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O, Moore J, Koller M, Turhal NS, Stuart R, van Cutsem E, D'haese S, Coens C. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer. 2004;40:2260–2268. doi: 10.1016/j.ejca.2004.05.023.
    1. Mousavi SM, Gouya MM, Ramazani M, Davanlou N, Hajsadeghi N, Sedighi Z. Cancer incidence and mortality in Iran. Ann Oncol. 2009;20:556–563. doi: 10.1093/annonc/mdn642.
    1. Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, Haji-Mahmoodi M. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version. Supportive Care Cancer. 1999;7:400–406. doi: 10.1007/s005200050300.
    1. Nunnally JC, Bernstein IR. Psychometric theory. New York: McGraw- Hill; 1994.
    1. Norman GR, Streiner DL. Biostatistics: The bare essentials. St. Louis, MO: Mosby; 1994.
    1. Huang CC, Lien HH, Sung YC, Liu HT, Chie WC. Quality of life of patients with gastric cancer in Taiwan: validation and clinical application of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-STO22. Psycho-Oncology. 2007;16:945–949. doi: 10.1002/pon.1158.
    1. Morita S, Kaptein AA, Oba K, Sakomoto J. The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data. Psycho-Oncology. 2008;17:474–479. doi: 10.1002/pon.1256.
    1. Kim WS, Park YH, Lee SH, Ryoo BY, Yang SH, Lee SS, Kim MS, Kim K, Park KW, Im do H, Kang JH, lee J, Ko YH, ahn YC, Lom do H, Park K, Bang SM. Quality of life one year after chemoradiotherapy for localized primary gastric diffuse large B-cell lymphoma. Med Oncol. 2008;25:447–450. doi: 10.1007/s12032-008-9065-z.
    1. Alawadi SA, Ohaeri JU. Health-related quality of life of Kuwaiti women with breast cancer: a comparative study using the EORTC Quality of Life Questionnaire. BMC Cancer. 2009;9:222. doi: 10.1186/1471-2407-9-222.
    1. Sadighi S, Mohagheghi MA, Montazeri A, Sedighi Z. Quality of life in Patients with advanced gastric cancer: a randomized trial comparing TCF with ECF. BMC Cancer. 2006;6:274. doi: 10.1186/1471-2407-6-274.
    1. Bae JM, kun S, Kim YW, Ryu KW, Lee JH, Noh JH, Sohn TS, Hong SK, Park SM, You CH, Kim JH, Lee MK, Yun YH. Health-related quality of life among disease-free stomach cancer survivors in Korea. Qual Life Res. 2006;15:1587–1596. doi: 10.1007/s11136-006-9000-8.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir